Role of activation-induced cell death in pathogenesis of patients with chronic hepatitis B

Table 1 AICD ratio of each group (x^-±s)

Group	n	AICD Ratio (%)
Patient with induction	26	17.24 ± 1.21a,b,c
Patient without induction	26	9.88 ± 1.36b
Healthy control with induction	15	6.63 ± 1.00c
Healthy control without induction	15	6.44 ± 1.01

^aP < 0.01 (F = 164.34) vs. other groups;

^bP < 0.01 (F = 660.45) vs. healthy control groups;

^cP < 0.01 (F = 326.37) vs. without induc-tion groups.